Healthcare provider profile · identity verified

Christopher P Hermann, MD

General Practice · DOYLESTOWN, PA · NPI 1063469344

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	332	71
Levothyroxine Sodium	Levothyroxine Sodium	307	69
Furosemide	Furosemide	172	29
Lisinopril	Lisinopril	163	45
Amlodipine Besylate	Amlodipine Besylate	160	41
Losartan Potassium	Losartan Potassium	158	38
Simvastatin	Simvastatin	157	45
Metoprolol Succinate	Metoprolol Succinate	137	33
Glimepiride	Glimepiride	130	27
Pantoprazole Sodium	Pantoprazole Sodium	125	24
Lorazepam	Lorazepam	117	37
Hydrochlorothiazide	Hydrochlorothiazide	114	33
Omeprazole	Omeprazole	108	27
Rosuvastatin Calcium	Rosuvastatin Calcium	105	25
Prednisone	Prednisone	104	71
Gabapentin	Gabapentin	103	32
Clopidogrel	Clopidogrel Bisulfate	100	17
Metformin Hcl Er	Metformin Hcl	97	31
Tamsulosin Hcl	Tamsulosin Hcl	96	26
Sertraline Hcl	Sertraline Hcl	95	22
Allopurinol	Allopurinol	89	21
Atenolol	Atenolol	87	23
Tramadol Hcl	Tramadol Hcl	83	21
Metformin Hcl	Metformin Hcl	80	20
Spironolactone	Spironolactone	76	17
Meloxicam	Meloxicam	74	17
Repaglinide	Repaglinide	74	16
Jardiance	Empagliflozin	73	12
Eliquis	Apixaban	66	14
Oxybutynin Chloride Er	Oxybutynin Chloride	64	18
Metoprolol Tartrate	Metoprolol Tartrate	63	16
Amoxicillin	Amoxicillin	62	40
Duloxetine Hcl	Duloxetine Hcl	61	15
Januvia	Sitagliptin Phosphate	60	15
Ezetimibe	Ezetimibe	59	12
Carvedilol	Carvedilol	57	12
Potassium Chloride	Potassium Chloride	55	14
Synthroid	Levothyroxine Sodium	53	14
Clonazepam	Clonazepam	52	13
Buspirone Hcl	Buspirone Hcl	51	12
Albuterol Sulfate Hfa	Albuterol Sulfate	49	15
Zolpidem Tartrate	Zolpidem Tartrate	48	17
Azithromycin	Azithromycin	45	40
Montelukast Sodium	Montelukast Sodium	45	suppressed
Alprazolam	Alprazolam	40	15
Cephalexin	Cephalexin	40	26
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	39	suppressed
Levofloxacin	Levofloxacin	39	30
Celecoxib	Celecoxib	37	suppressed
Famotidine	Famotidine	37	12
Candesartan Cilexetil	Candesartan Cilexetil	33	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	26
Finasteride	Finasteride	31	suppressed
Midodrine Hcl	Midodrine Hcl	31	suppressed
Pregabalin	Pregabalin	31	suppressed
Valsartan	Valsartan	31	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Bumetanide	Bumetanide	30	suppressed
Doxepin Hcl	Doxepin Hcl	30	suppressed
Enalapril Maleate	Enalapril Maleate	30	suppressed
Ipratropium Bromide	Ipratropium Bromide	30	12
Ozempic	Semaglutide	29	suppressed
Hydrocortisone	Hydrocortisone	28	suppressed
Meclizine Hcl	Meclizine Hcl	28	suppressed
Acebutolol Hcl	Acebutolol Hcl	27	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	27	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Diazepam	Diazepam	22	suppressed
Glipizide	Glipizide	22	suppressed
Methenamine Hippurate	Methenamine Hippurate	22	suppressed
Verapamil Er	Verapamil Hcl	22	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Invokana	Canagliflozin	20	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Digoxin	Digoxin	16	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Testosterone	Testosterone	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Cefadroxil	Cefadroxil	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Febuxostat	Febuxostat	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Serevent Diskus	Salmeterol Xinafoate	11	suppressed
Temazepam	Temazepam	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error